Paper3980561
Survival of human bone marrow cells after in vitro treatment with 12 anticancer drugs and implications for tumor drug sensitivity assays.
Umbach GE and 6 others. J Cancer Res Clin Oncol, 1985. Cited by 9 papers, by iCite.
Cite this record
ConductScience Library. Survival of human bone marrow cells after in vitro treatment with 12 anticancer drugs and implications for tumor drug sensitivity assays. Papers, record 3980561. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3980561
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antineoplastic Agents | Major topic |
| Bone Marrow | Major topic |
| Colony-Forming Units Assay | Major topic |
| Tumor Stem Cell Assay | Major topic |
| Cell Survival | |
| Dose-Response Relationship, Drug | |
| Hematopoietic Stem Cells | |
| Humans |
Source PubMed
Grants4
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| CA 14528 | NCI NIH HHS | United States | P01CA014528 | PubMed and NIH | NIH RePORTER |
| CA 23272 | NCI NIH HHS | United States | R01CA023272 | PubMed and NIH | NIH RePORTER |
| CA 28153 | NCI NIH HHS | United States | P01CA028153 | PubMed and NIH | NIH RePORTER |
| P02CA014528 | NIH | NIH RePORTER |
References21
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 7318145 | Potentials and possible pitfalls of human stem cell analysis. | Cancer Chemother Pharmacol | 1981 | https://conductscience.org/library/papers/7318145 | PubMed |
| 2 | 4125097 | The sensitivity to bleomycin of spleen colony forming units in the mouse. | Br J Cancer | 1973 | https://conductscience.org/library/papers/4125097 | PubMed |
| 3 | 6951071 | 5-Fluorouracil, 1,3-bis(2-chloroethyl)-1-nitrosourea, and 1-(2-chloroethyl)-3-(4-methylcyclohexyl)-1-nitrosourea: effect on the human granulopoietic system. | J Natl Cancer Inst | 1982 | https://conductscience.org/library/papers/6951071 | PubMed |
| 4 | 6572563 | Clinical correlations of leukemic clonogenic cell chemosensitivity assessed by in vitro continuous exposure to drugs. | Cancer Res | 1983 | https://conductscience.org/library/papers/6572563 | PubMed |
| 5 | 1087180 | The reversal of methotrexate cytotoxicity to mouse bone marrow cells by leucovorin and nucleosides. | Cancer Res | 1976 | https://conductscience.org/library/papers/1087180 | PubMed |
| 6 | 7193870 | In vitro drug assay: pharmacologic considerations. | Prog Clin Biol Res | 1980 | https://conductscience.org/library/papers/7193870 | PubMed |
| 7 | 6838146 | Clinical application of the clonogenic assay. | Ann Clin Lab Sci | 1983 | https://conductscience.org/library/papers/6838146 | PubMed |
| 8 | 387224 | cis-Dichlorodiammineplatinum(II) for the treatment of advanced ovarian cancer. | Cancer Treat Rep | 1979 | https://conductscience.org/library/papers/387224 | PubMed |
| 9 | 4113143 | The response of human lymphoma cells in vitro to bleomycin and 1,3-bis(2-chloroethyl)-1-nitrosourea. | Cancer Res | 1972 | https://conductscience.org/library/papers/4113143 | PubMed |
| 10 | 16398024 | Colony stimulating factor augmentation in human placental conditioned medium. | Exp Hematol | 1980 | https://conductscience.org/library/papers/16398024 | PubMed |
| 11 | 734053 | Radiobiological techniques applied to environmental problems. | Radiat Res | 1978 | https://conductscience.org/library/papers/734053 | PubMed |
| 12 | 6891626 | Human tissue distribution of platinum after cis-diamminedichloroplatinum. | Cancer Chemother Pharmacol | 1982 | https://conductscience.org/library/papers/6891626 | PubMed |
| 13 | 6837681 | Soft agar colony formation assay for in vitro testing of sensitivity to chemotherapy of gynecologic malignancies. | Am J Obstet Gynecol | 1983 | https://conductscience.org/library/papers/6837681 | PubMed |
| 14 | 640566 | [Testing the resistance of human tumor and bone marrow cells to cytostatic agents]. | Fortschr Med | 1978 | https://conductscience.org/library/papers/640566 | PubMed |
| 15 | 6339044 | Prospective clinical trial of a human tumor cloning system. | Cancer Res | 1983 | https://conductscience.org/library/papers/6339044 | PubMed |
| 16 | 6339049 | Radiation sensitivity of leukemic progenitor cells in acute nonlymphocytic leukemia. | Cancer Res | 1983 | https://conductscience.org/library/papers/6339049 | PubMed |
| 17 | 6692414 | Normalization of in vitro sensitivity testing of human tumor clonogenic cells. | Cancer Res | 1984 | https://conductscience.org/library/papers/6692414 | PubMed |
| 18 | 6683465 | Cis-platinum in the treatment of advanced or recurrent adenocarcinoma of the ovary. A phase II study of the Gynecologic Oncology Group. | Am J Clin Oncol | 1983 | https://conductscience.org/library/papers/6683465 | PubMed |
| 19 | 594662 | Studies on the regeneration of the CFU-C population in blood and bone marrow of lethally irradiated dogs after autologous transfusion of cryopreserved mononuclear blood cells. | Scand J Haematol | 1977 | https://conductscience.org/library/papers/594662 | PubMed |
| 20 | 749923 | Changes of granulopoiesis during and after adjuvant chemotherapy of breast cancer. | Br J Haematol | 1978 | https://conductscience.org/library/papers/749923 | PubMed |
Cited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 9 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 18596744 | Preferential sensitivity of hematopoietic (HPs) and mesenchymal (MPs) progenitors to fludarabine suggests impaired bone marrow niche and HP mobilization. | Leukemia | 2008 | https://conductscience.org/library/papers/18596744 | PubMed |
| 3778805 | In vitro cytotoxicity patterns of standard and investigational agents on human bone marrow granulocyte-macrophage progenitor cells. | Br J Cancer | 1986 | https://conductscience.org/library/papers/3778805 | PubMed |
| 2803923 | Potential therapeutic role of cisplatinum in autologous bone marrow transplantation: in vitro eradication of neuroblastoma cells from bone marrow. | Br J Cancer | 1989 | https://conductscience.org/library/papers/2803923 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/3980561
GET https://conductscience.org/api/papers/v1/3980561/references?page=2